Rwanda's first cancer centre, opened in 2012 in a rural district hospital by Partners In Health and the Rwandan government, proving that complex cancer care can be delivered in low-income settings.
The Butaro Cancer Center of Excellence opened in 2012 at Butaro District Hospital in Rwanda's Northern Province, built by Partners In Health with the Rwanda Ministry of Health and support from Dana-Farber/Brigham and Women's Cancer Center and the Jeff Gordon Children's Foundation, as the country's first facility dedicated to cancer care. It provides pathology, chemotherapy, surgery and palliative care to Rwandan and regional patients, with radiotherapy referred to Kigali since the Rwanda Cancer Centre opened there, and it has published outcomes for Wilms tumour, Burkitt and Hodgkin lymphoma, breast and cervical cancer showing that protocol-based treatment with task-shifting and telepathology is feasible in a rural low-income setting. Butaro also hosts the University of Global Health Equity campus and trains oncology nurses and clinicians for East Africa.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Butaro Hospital, including child institutions. 5 works · 9 citations · 80% open access · 0% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert® mRNA expression assay 10.2471/blt.22.288800 · open access | Bulletin of the World Health Organization | 2023 | 9 |
| Impact of Patient Navigation on Time to Treatment Among Patients With GI Cancers at Rwanda Military Referral and Teaching Hospital 10.1200/go-25-00339 · open access | JCO Global Oncology | 2026 | 0 |
| 933 Global Dermatopathology Consultations from Resource-Limited Countries: Diagnostic Patterns and Technical Challenges 10.1016/j.labinv.2025.105222 | Laboratory Investigation | 2026 | 0 |
| Referral Patterns and Delays in the Care of Patients With Breast Complaints in Rwanda: A Cohort Study From a Tertiary Hospital 10.1200/go-25-00345 · open access | JCO Global Oncology | 2026 | 0 |
| Epidemiological characterization of hormonal receptor profiles and associated histopathological characteristics in Rwandan women with breast cancer: a retrospective study | Research Square | 2023 | 0 |
Shares WHO Essential Medicines List for cancer, Global oncology and access in low- and middle-income countries, Cervical cancer, Diffuse large B-cell lymphoma.
Shares WHO Essential Medicines List for cancer, Global oncology and access in low- and middle-income countries, Cervical cancer, HR-positive / HER2-negative breast cancer.
Shares WHO Essential Medicines List for cancer, Global oncology and access in low- and middle-income countries, Cervical cancer, HR-positive / HER2-negative breast cancer.
Shares Telemedicine, teleoncology, and telepathology, Digital pathology & AI.
Shares Digital pathology & AI, Cervical cancer, HR-positive / HER2-negative breast cancer.
Shares Global oncology and access in low- and middle-income countries, Cervical cancer, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
Shares Global oncology and access in low- and middle-income countries, Cervical cancer, HR-positive / HER2-negative breast cancer.
Shares Telemedicine, teleoncology, and telepathology, Global oncology and access in low- and middle-income countries, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.